NCT01220817View on ClinicalTrials.gov

Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month Study

PHASE2CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Recurrent Prostate Cancer
Interventions
DRUG

3 POMx capsules

3 POMx capsules daily

DRUG

1 POMx capsule

1 POMx capsule daily

Trial Locations (1)

21205

Johns Hopkins University, Baltimore

All Listed Sponsors
lead

POM Wonderful LLC

INDUSTRY

NCT01220817 - Safety and Efficacy of POMx Capsules in Men With Recurrent Prostate Cancer: An 18-Month Study | Biotech Hunter | Biotech Hunter